BMG762791017
BMG762791017
Roivant Sciences Ltd.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 8.260.000 | 29.053.000 | 71.6% |
| Cost of Revenue | 1.285.000 | 911.000 | 41.1% |
| Gross Profit | 6.975.000 | 28.142.000 | 75.2% |
| 1.292.278.000 | 1.141.823.000 | 13.2% | |
| Operating Income | -1.285.303.000 | -1.113.681.000 | 15.4% |
| Pretax Income | -264.578.000 | -681.590.000 | 61.2% |
| Net Income Common Stockholders | -299.771.000 | -171.981.000 | 74.3% |
| -- | -- | -- | |
| -- | -- | -- |